Men lose key immune cells faster as they age

As people age, the thymus, the organ that produces young immune cells, shrinks. In men, this process starts earlier and progresses more quickly than in women. The result is a reduced supply of so-called naive CD8+ T cells, the immune cells the body uses to recognize new threats, including cancer cells and unfamiliar pathogens.

The researchers, publishing in the journal Nature Aging, studied both male mice and men. In both, they found that faster thymic shrinkage leads to a reduced capacity to recognize tumor cells. Male mice also showed a weaker response to immunotherapy, a treatment that harnesses the body’s own immune system against cancer.

Thymic shrinkage affects cancer treatment response

What makes this research compelling for longevity science is the direct link between immune aging and the effectiveness of cancer therapy. If immune cells age faster in men, this could help explain why men are more susceptible to certain cancers at earlier ages and why immunotherapy may be less effective in them.

The connection between thymic involution and immune aging is not new. What is new is the direct demonstration of a sex difference in this process and its functional consequences for tumor recognition. The researchers suggest that slowing or reversing thymic shrinkage might be a strategy for treating immune aging in men. This remains a hypothesis that requires further study.

Sex differences in immune aging are understudied

Immune aging is a well-researched topic, but studies explicitly examining biological sex differences in this process are rarer. This work offers a tangible connection: the sex difference in thymic shrinkage may be one reason men live shorter lives on average and are more vulnerable to certain age-related diseases. Whether and how this difference can be modified remains an open question.

Read the original article